- US12539308utility2026Immune-enhancing Rnas for Combination with Chimeric Antigen Receptor Therapy0 cites
- US12533340utility2026Treatment of Autoimmune Disease in a Patient Receiving Additionally a Beta-blocker0 cites
- US12533468utility2026Automatic Drug Delivery Device0 cites
- US12527841utility2026Fibroblast Growth Factor-21-fc Fusion Proteins0 cites
- US12497449utility2025Methods of Treating Autoimmune Diseases Using Interleukin-17 (IL-17) Antagonists0 cites
- US12497616utility2025Compounds Targeting PMP22 for the Treatment of Charcot-marie-tooth Disease0 cites
- US12491231utility2025Methods of Treating Metabolic Disorders with FGF21 Variants0 cites
- US12492265utility2025Anti-ige Antibody Therapy for Multiple Food Allergies0 cites
- US12485172utility2025Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies0 cites
- US12485173utility2025Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies0 cites
- US12479817utility2025Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and Uses Thereof0 cites
- US12473273utility2025Quinoline Compounds and Compositions for Inhibiting EZH20 cites
- US12465635utility2025Methods of Treating Inflammatory Arthritis Using Secukinumab0 cites
- US12466808utility2025Aminopyridine Derivatives and Their Use as Selective ALK-2 Inhibitors0 cites
- US12466821utility2025Antiviral Pyridopyrazinedione Compounds0 cites
- US12453726utility2025Methods of Using Factor B Inhibitors0 cites
- US12441737utility2025Manufacture of Compounds and Compositions for Inhibiting the Activity of SHP20 cites
- US12441786utility2025Bispecific Antibodies for Use in Treatment of NLRC4-GOF Inflammasomapathy0 cites
- US12433949utility2025Sustained Release Delivery Systems Comprising Traceless Linkers0 cites